The stock’s performance today recorded a gain of 0.47%, outpacing the Sensex which moved by 0.11%, and outperforming its sector by 1.68%. This upward momentum is supported by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained strength in price trends.
Over the short term, Zota Health Care’s weekly performance stands at 7.57%, significantly ahead of the Sensex’s 0.95% movement. The monthly figures also reflect a positive trend with a 5.92% change compared to the Sensex’s 1.09%. These figures indicate that the stock has been consistently outperforming the broader market and its sector peers in recent weeks.
Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.
- - New Reliable Performer
- - Steady quarterly gains
- - Fertilizers consistency
Looking at the medium-term performance, Zota Health Care’s three-month return is 25.76%, a substantial margin above the Sensex’s 4.18%. This trend extends over the year, where the stock’s performance is recorded at 198.57%, dwarfing the Sensex’s 9.93% for the same period. Year-to-date figures also show a 106.75% change for Zota Health Care, compared to the Sensex’s 9.14%, underscoring the stock’s robust trajectory throughout the current year.
Examining the longer-term horizon, the three-year performance of Zota Health Care is particularly striking at 529.41%, vastly exceeding the Sensex’s 38.30%. Over five years, the stock’s growth reaches an impressive 1088.59%, while the Sensex recorded 94.34% in the same timeframe. These figures highlight the company’s sustained growth and value creation over an extended period within the Pharmaceuticals & Biotechnology sector.
Zota Health Care or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
The market capitalisation grade for Zota Health Care is noted as 3, reflecting its standing within the small-cap segment of the Pharmaceuticals & Biotechnology industry. The stock’s ability to maintain trading levels above all major moving averages further reinforces the strength of its price action and investor confidence in its valuation.
While the stock has not recorded any change over a ten-year period, this is consistent with the data available and does not detract from the notable gains observed over shorter and medium-term intervals. The company’s performance relative to the Sensex and its sector peers demonstrates a clear pattern of outperformance, particularly over the last five years.
In summary, Zota Health Care’s attainment of its all-time high price of Rs.1712.7 is a testament to its sustained market presence and growth within the Pharmaceuticals & Biotechnology sector. The stock’s consistent outperformance across multiple timeframes highlights its significant journey and the strength of its market positioning.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
